Growth hormone neuroregulation and the clinical relevance of somatostatin
- 1 November 1983
- journal article
- Published by Elsevier in Clinics in Endocrinology and Metabolism
- Vol. 12 (3) , 695-724
- https://doi.org/10.1016/s0300-595x(83)80061-9
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- CHANGES IN CIRCULATING SOMATOMEDIN-C LEVELS IN BROMOCRIPTINE-TREATED ACROMEGALYClinical Endocrinology, 1982
- The regional distribution and chromatographic behaviour of somatostatin in human brainNeuroscience Letters, 1981
- Somatostatinoma SyndromeNew England Journal of Medicine, 1979
- Treatment of Bleeding Esophageal Varices with SomatostatinNew England Journal of Medicine, 1978
- THE ROLE OF SEROTONIN AND DOPAMINE IN HYPOTHALAMIC‐PITUITARY FUNCTIONClinical Endocrinology, 1977
- “Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine PancreasNew England Journal of Medicine, 1977
- Reversal of somatostatin inhibition of insulin secretion by calciumBiochemical and Biophysical Research Communications, 1974
- Inhibition of adenosine 3′,5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormoneBiochemical and Biophysical Research Communications, 1974
- Solid phase synthesis of growth hormone-release inhibiting factorBiochemical and Biophysical Research Communications, 1973
- Synthesis of a peptide with full somatostatin activityBiochemical and Biophysical Research Communications, 1973